Clinical Trial Update: The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure [Phase 4]

View source ↗

Summary

Clinical trial comparing spironolactone and indapamide, alone or with amlodipine, for reducing heart failure risk in hypertension (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Indapamide (Indapamide)
• Spironolactone (spironolactone)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Hypertension | Phase 4 | Status: UNKNOWN